These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3510146)

  • 21. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
    Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
    Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azathioprine hepatotoxicity after liver transplantation.
    Sterneck M; Wiesner R; Ascher N; Roberts J; Ferrell L; Ludwig J; Lake J
    Hepatology; 1991 Nov; 14(5):806-10. PubMed ID: 1937385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide (CP) substituting azathioprine after renal transplantation.
    Andreu J; Caralps A; Brulles A; Lloveras J; Masramon J; Gil-Vernet JM
    Proc Eur Dial Transplant Assoc; 1976; 12():434-40. PubMed ID: 778835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient].
    Hola K; Brahm J; Alvo M; Cotera A; Passalacqua W; Smok G
    Rev Med Chil; 1996 Dec; 124(12):1489-91. PubMed ID: 9334484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatotoxicity of azathioprine in renal transplant recipients.
    Ramalho HJ; Terra EG; Cartapatti E; Barberato JB; Alves VA; Gayotto LC; Abbud-Filho M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1716-7. PubMed ID: 2652562
    [No Abstract]   [Full Text] [Related]  

  • 26. [Liver injury in kidney transplant patients receiving azathioprine (author's transl)].
    Obata T; Watanabe A; Hayashi S; Higashi T; Endo H; Nagashima H; Horimi T; Huchimoto S; Sakagami K; Orita K
    Nihon Shokakibyo Gakkai Zasshi; 1980 Jan; 77(1):32-42. PubMed ID: 6987436
    [No Abstract]   [Full Text] [Related]  

  • 27. Liver disease in renal transplant recipients.
    Sopko J; Anuras S
    Am J Med; 1978 Jan; 64(1):139-46. PubMed ID: 203190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of liver disease in renal transplant recipients.
    Ware AJ; Luby JP; Eigenbrodt EH; Long DL; Hull AR
    Gastroenterology; 1975 Apr; 68(4 Pt 1):755-64. PubMed ID: 164401
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
    Duvoux C; Kracht M; Lang P; Vernant JP; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1991; 15(12):968-73. PubMed ID: 1783253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of hepatic venocclusive disease in a bone marrow transplant patient with side-to-side portacaval shunt.
    Murray JA; LaBrecque DR; Gingrich RD; Pringle KC; Mitros FA
    Gastroenterology; 1987 Apr; 92(4):1073-7. PubMed ID: 3549421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
    Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J
    Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is nodular regenerative hyperplasia of the liver associated with azathioprine therapy after renal transplantation?
    Jones MC; Best PV; Catto GR
    Nephrol Dial Transplant; 1988; 3(3):331-3. PubMed ID: 3140109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
    Bryant DL; Miles CJ; Gearry RB
    N Z Med J; 2010 Apr; 123(1313):74-6. PubMed ID: 20581898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic dysfunction after renal transplantation in children.
    Malekzadeh MH; Grushkin CM; Wright HT; Fine RN
    J Pediatr; 1972 Aug; 81(2):279-85. PubMed ID: 4339534
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cholestasis after renal transplantation and immune-suppressive therapy (author's transl)].
    Schmidt P; Balcke P; Zazgornik J; Kopsa H; Altrichter H; Türk H
    Leber Magen Darm; 1979 Feb; 9(1):11-4. PubMed ID: 368472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe azathioprine-induced liver injury 22 months after initiation of treatment.
    Cataletti G; Santagata F; Pastorelli L; Battezzati PM
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36543371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause?
    Liaño F; Moreno A; Matesanz R; Teruel JL; Redondo C; García-Martín F; Orte L; Ortuño J
    Nephron; 1989; 51(4):509-16. PubMed ID: 2662036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study and long-term follow-up of liver damage in renal transplant recipients.
    Takahara S; Ihara H; Ichikawa Y; Nagano S; Fukunishi T; Sonoda T; Shinji Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2221-4. PubMed ID: 3547920
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
    Kusaba R; Otubo O; Sugimoto H; Takahashi I; Yamada Y; Yamauchi J; Akiyama N; Inou T
    Proc Eur Dial Transplant Assoc; 1981; 18():420-5. PubMed ID: 7036163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.